Thus through CXCR4/CXCL12 axis leukemia cells are protected by the stromal cells from cytotoxic chemotherapeutics and represent a reservoir for minimal residual disease and relapses2, 13, 14. This evidence concerns the gene CXCL12 and leukemia.